Cipher Pharmaceuticals
6560 Kennedy Road
Mississauga
Ontario
L5T 2X4
Canada
Tel: 905-565-0043
Fax: 905-565-1776
235 articles about Cipher Pharmaceuticals
-
Cipher Pharma Receives Health Canada Approval Of (Pr)Beteflam
12/7/2015
-
Cipher Pharma To Present At Piper Jaffray Healthcare Conference 2015
11/25/2015
-
Cipher Pharma Reports Third Quarter Results
11/4/2015
-
Cipher Pharma Q3 2015 Conference Call
10/21/2015
-
Cipher Pharma Announces Settlement In Patent Litigation For Absorica
10/5/2015
-
Cipher Pharma Reports Financial And Operational Results For Q2 2015
8/14/2015
-
Cipher Pharma Announces Acceptance Of 510(K) Submission For Dermadexin By FDA
8/4/2015
-
Notice Of Cipher Pharma Q2 2015 Conference Call
7/31/2015
-
Cipher Pharma Announces Successful Completion Of Second Phase III For Ozenoxacin
7/30/2015
-
Cipher Pharma To Present At 2015 JMP Securities Life Sciences Conference
6/19/2015
-
Cipher Pharma To Present At BIO International Convention
6/4/2015
-
Cipher Pharma Strengthens Leadership Team With Key Executive Appointments And Announces Launch Of Vaniqa In Canada
6/2/2015
-
Cipher Pharma To Present At Jefferies and Co. 2015 Global Healthcare Conference
5/28/2015
-
Cipher Pharma Reports Voting Results From Annual And Special Meeting Of Shareholders
5/14/2015
-
Cipher Pharma Reports Financial And Operational Results For Q1 2015
5/13/2015
-
Cipher Pharma Reports Financial And Operational Results For Q1 2015
5/13/2015
-
Cipher Pharma Acquires Canadian Commercialization Rights To Vaniqa And Actikerall
5/6/2015
-
Notice Of Cipher Pharma Q1 2015 Conference Call And 2014 Annual And Special Meeting Of Shareholders
4/29/2015
-
Cipher Pharma Announces Outcome Of Markman Hearing In Patent Infringement Suit For Absorica
4/24/2015
-
Cipher Pharma To Present At 2015 Bloom Burton & Co. Healthcare Investor Conference
4/22/2015